Acknowledgements

Last revised: 29 Sep 2021


The RACGP is grateful for the expert advice from the following content advisors who contributed to the 2021 update of the guidelines:

Professor Nicholas Zwar (Chair) – Executive Dean, Faculty of Health Sciences and Medicine, Bond University, Queensland

Ms Emma Dean – Health Systems Reform Manager, Quit Victoria

Associate Professor Mathew Coleman – Rural and Remote Mental Health Practice, Rural Clinical School of Western Australia, University of Western Australia

Professor Christine McDonald, Respiratory medicine and Lung Foundation, Austin Hospital Victoria

Professor Nicholas Buckley, Professor of Clinical Pharmacology and Medical toxicologist, University of Sydney and NSW Health

Dr Shane Jackson, Pharmaceutical Society of Australia, ACT

A/Prof Rowena Ivers, General Practitioner with special interest in Aboriginal and Torres Strait Islander health, NSW

Dr Hester Wilson, General Practitioner with special interest in Addiction Medicine, NSW

Mr William Parry, Assistant Director, Tobacco Control Section, Australian Government Department of Health

Ms Belinda Nowland, Tobacco Control and Other Dugs Branch, Australian Government Department of Health

Ms Emily Tadros, Tobacco Control and Other Drugs Branch, Australian Government Department of Health

Ms Jenny Francis, Principal Legal and Policy Adviser, Regulatory Legal Services, Health Products Regulation Group, Australian Government Department of Health

Other contributors

Writing

Ms Winnie Yong, Health Writer, Indelible Healthcare Communications, New South Wales

Technical support and evidence summaries

Professor Emily Banks, Public Health, NCEPH, Australian National University, ACT

Dr Amelia Yazidjoglou, Public Health, NCEPH, Australian National University, ACT

Dr Cathy Day, Research Manager, NCEPH, Australian National University, ACT

Disclosure of interests

Professor Nicholas Zwar has previously provided expert advice on smoking cessation education programs to Pfizer Pty Ltd and GlaxoSmithKline Australia Pty Ltd, and has received support to attend smoking cessation conferences. However, he has no interests to declare in the last five years. He is currently co-chair of the Australian Professional Society on Alcohol and other Drugs Smoking Cessation Special Interest Group.

Ms Emma Dean is employed by Quit / Cancer Council Victoria, which delivers the not-for-profit Quitline service in Victoria, South Australia, Western Australia and the Northern Territory. Emma represented Alfred Health at an Exchange Summit in 2018 which was supported by Pfizer however she did not personally receive an honorarium.

Associate Professor Mathew Coleman is a consultant psychiatrist and RANZCP Fellow. He has received an honorarium from Pfizer to present at a Smoking Cessation Summit in 2019.

Professor Christine McDonald declared no conflicting interests.

Professor Nicholas Buckley declared no conflicting interests.

Dr Shane Jackson is a community pharmacy owner.

A/Prof Rowena Ivers declared no conflicting interests.

Dr Hester Wilson declared no conflicting interests.

Mr William Parry declared no conflicting interests.

Ms Belinda Nowland declared no conflicting interests.

Ms Emily Tadros declared no conflicting interests.

Ms Jenny Francis declared no conflicting interests.

Stakeholder consultation process

The RACGP undertook a targeted consultation process for updating advice on nicotine vaping products. The Expert Advisory Group gratefully acknowledges the expert reviewers and representatives from the organisations who contributed scholarly feedback:

Australian Commonwealth Government Departments of Health

Alcohol, Tobacco and Other Drugs Branch

Therapeutic Goods Administration

Pharmacological & Special Access Branch

State Departments of Health

Victorian Government, Department of Health

NSW Health

Queensland Health

WA Health

SA Health

Tasmanian Government, Department of Health

NT Health

Non-Governmentt & Not- for-Profit Organisations

Lung Foundation

Heart Foundation

Thoracic Society

Stroke Foundation

Cancer Victoria

Diabetes Australia

Consumer Health Forum of Australia

National Aboriginal Community Controlled Health Organisation

Medical Defence

MDA National – mutual Medical Defence Organisation

Avant Medical Indemnity Insurance

MIPS – Medical Indemnity Protection Society

MIGA – Medical Insurance Group Australia

Medical Colleges & Societies

Australian College of Rural and Remote Medicine

Pharmaceutical Society Australia

Pharmacy Guild

Royal Australian College of Physicians

Australian College of Nursing

Australian Medical Association

Royal Australian & New Zealand College of Psychiatrists

Feedback on the use of nicotine vaping products among Aboriginal and Torres Strait Islander communities

Dr Sophie Dwyer, Public Health Registrar, NACCHO, ACT

Dr Michelle Kennedy, NHMRC Early Career Research Fellow, Thurru Indigenous Health Unit, School of Medicine and Public Health, University of Newcastle

Professor David Thomas, Head, Tobacco Control Research, Menzies School of Health Research, Charles Darwin University

Other individual feedback

Professor Chris Bullen, Professor of Public Health, National Institute for Health Innovation, School of Population Health, Faculty of Medical and Health Sciences, The University of Auckland, NZ.


Expert Advisory Group

The RACGP is grateful for the expert advice from the following content advisors who contributed to the second edition of the guideline.

Professor Nicholas Zwar (Chair) – Executive Dean, Faculty of Health Sciences and Medicine, Bond University, Queensland

Professor Robyn Richmond – School of Public Health and Community Medicine, UNSW Sydney, New South Wales

Professor Ron Borland – School of Psychological Science, University of Melbourne, Victoria

Professor Matthew Peters – Respiratory Medicine, Concord Hospital, New South Wales

Conjoint Associate Professor Colin Mendelsohn – School of Public Health and Community Medicine, UNSW Sydney, New South Wales; Chair, Australian Tobacco Harm Reduction Association

Associate Professor John Litt – College of Medicine and Public Health, Flinders University, South Australia; General Practitioner (retired); Ambassador, Cancer SA

Ms Emma Dean – Senior Pharmacist and Project Officer, Alfred Health, Victoria

Associate Professor Mathew Coleman – Rural and Remote Mental Health Practice, Rural Clinical School of Western Australia, University of Western Australia

Ms Kath Sharples – Australian College of Nursing, New South Wales

Mr Scott Walsberger – Heart Health Manager NSW, National Heart Foundation of Australia, New South Wales

Mr George Masri – Assistant Secretary, Tobacco Control Branch (QUIT National), Department of Health, ACT (October–December 2017)

Mr John Power – Acting Director, Tobacco Control Branch, Population Health and Sport Division, Department of Health, ACT (December 2017 – July 2018)

Other contributors

Ms Rhonda Matthews – Senior Project Officer, Centre for Population Health, NSW Health, New South Wales

Ms Mary Sinclair – Medical Writer, New South Wales

Stakeholder consultation process

The RACGP undertook a six-week targeted consultation with a broad range of stakeholders. The Expert Advisory Group gratefully acknowledges the expert reviewers and representatives from the organisations who contributed scholarly feedback.

Alcohol and Drug Services, Department of Health and Human Services, Tasmania
Australasian Professional Society on Alcohol and other Drugs
Australian College of Nursing
Australian Government Department of Health
Cancer Council Australia
Cancer Council Victoria
Consumers Health Forum of Australia
National Heart Foundation of Australia
NSW Ministry of Health
Public Health Services, Department of Health and Human Services, Tasmania
RACGP Specific Interests – Addiction Medicine network
RACGP Specific Interests – Respiratory network
Royal Australian and New Zealand College of Psychiatrists
Royal Australasian College of Physicians
SA Health
Stroke Foundation

Feedback on supporting smoking cessation for Aboriginal and Torres Strait Islander peoples

Ms Ada Parry, Cultural and Education Advisor, RACGP Aboriginal and Torres Strait Islander Health

Dr Michelle Bovill, NHMRC Early Career Research Fellow, School of Medicine and Public Health, University of Newcastle

Professor David Thomas, Tobacco Control Research, Menzies School of Health Research, Charles Darwin University

Other individual feedback

Dr Johnson George – Senior Lecturer, Centre for Medicine Use and Safety, Monash University; member, Lung Foundation Australia COPD-X Guidelines Committee

Conflicts of interest

This guideline was developed in accordance with the rules and processes outlined in the RACGP’s Conflict of Interest Policy.

All Expert Advisory Group members completed a Declaration of Interests register before the commencement of guideline development. Any potential conflicting interests further arising were declared at the start of all meetings and recorded appropriately. If a member declared an interest that was identified as a conflict to a specific intervention, they did not participate in the decision making and were excluded from the voting process for that particular recommendation. Disclosures of interests can be found below.

The second edition of the RACGP’s Supporting smoking cessation: A guide for health professionals was funded in part by the Australian Government Department of Health and VicHealth.
 

Disclosure of interests

Professor Nicholas Zwar has provided expert advice on smoking cessation education programs to Pfizer Pty Ltd and GlaxoSmithKline Australia Pty Ltd, and has received support to attend smoking cessation conferences. He has no interests to declare in the last five years.

Professor Ron Borland has developed QuitCoach, onQ and QuitTxt smoking cessation programs, but he has no commercial interest in them.

Associate Professor John Litt has provided smoking cessation advice and training at meetings supported by Pfizer Pty Ltd. He is a member of the Pfizer Champix Advisory Board, a member of the Pfizer Smoking Exchange Summit planning committee, and he spoke at the Exchange Smoking Cessation conference in Melbourne, October 2018.

Associate Professor Matthew Peters has received honoraria from Pfizer Pty Ltd for his contribution to the varenicline advisory board and for continuing medical education (CME) lectures at meetings supported by Pfizer Pty Ltd and GlaxoSmithKline Australia Pty Ltd in relation to asthma/chronic obstructive pulmonary disease treatments.

Associate Professor Colin Mendelsohn has received honoraria for teaching, consulting and conference expenses from Pfizer Pty Ltd, GlaxoSmithKline Australia Pty Ltd, Johnson & Johnson Pacific Pty Ltd and Perrigo Australia. He is chair of the Australian Tobacco Harm Reduction Association (ATHRA), a health promotion charity established to raise awareness of safer alternatives to smoking. While he contributed to discussion, he was not able to cast any votes on developing recommendations relating to e-cigarettes.

Ms Emma Dean is employed by Alfred Health. The Victorian Department of Health and Human Services, VicHealth and Victorian Aboriginal Community Controlled Health Organisation (VACCHO) fund Alfred Health to deliver prevention initiatives, including Smokefree.

Mr George Masri worked for the Department of Health, which contributed funding to update this smoking cessation guideline.

Mr John Power worked for the Department of Health, which contributed funding to update this smoking cessation guideline.

Associate Professor Mathew Coleman disclosed no conflicting interests.

Professor Robyn Richmond disclosed no conflicting interests.

Ms Kathryn Sharples disclosed no conflicting interests.

Mr Scott Walsberger disclosed no conflicting interests.